Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patien…
Biotechnology
US, Ponte Vedra [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cadrenal Therapeutics, Inc. Common Stock has no acquisition track records yet.
M&A Deals · History
Cadrenal Therapeutics, Inc. Common Stock has no acquisition track records yet.